nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP4A11—Dexamethasone—multiple sclerosis	0.0877	0.119	CbGbCtD
Phenobarbital—CYP1B1—Mitoxantrone—multiple sclerosis	0.0703	0.0949	CbGbCtD
Phenobarbital—CYP2E1—Fingolimod—multiple sclerosis	0.0507	0.0685	CbGbCtD
Phenobarbital—ABCC1—Mitoxantrone—multiple sclerosis	0.0499	0.0674	CbGbCtD
Phenobarbital—CYP1B1—Dexamethasone—multiple sclerosis	0.0364	0.0492	CbGbCtD
Phenobarbital—ABCB11—Dexamethasone—multiple sclerosis	0.0364	0.0492	CbGbCtD
Phenobarbital—ABCC3—Methotrexate—multiple sclerosis	0.0339	0.0458	CbGbCtD
Phenobarbital—CYP2A6—Prednisolone—multiple sclerosis	0.0317	0.0429	CbGbCtD
Phenobarbital—CYP2E1—Mitoxantrone—multiple sclerosis	0.0238	0.0322	CbGbCtD
Phenobarbital—ABCC1—Methotrexate—multiple sclerosis	0.0208	0.0281	CbGbCtD
Phenobarbital—ABCC2—Dexamethasone—multiple sclerosis	0.0192	0.0259	CbGbCtD
Phenobarbital—CYP2A6—Dexamethasone—multiple sclerosis	0.0187	0.0253	CbGbCtD
Phenobarbital—ABCB1—Methylprednisolone—multiple sclerosis	0.0165	0.0223	CbGbCtD
Phenobarbital—CYP1A1—Dexamethasone—multiple sclerosis	0.016	0.0216	CbGbCtD
Phenobarbital—ABCC2—Methotrexate—multiple sclerosis	0.0154	0.0208	CbGbCtD
Phenobarbital—CYP3A4—Fingolimod—multiple sclerosis	0.0154	0.0207	CbGbCtD
Phenobarbital—CYP3A7—Dexamethasone—multiple sclerosis	0.0128	0.0173	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0128	0.0173	CbGbCtD
Phenobarbital—CYP2C19—Prednisone—multiple sclerosis	0.0124	0.0168	CbGbCtD
Phenobarbital—CYP2E1—Dexamethasone—multiple sclerosis	0.0123	0.0167	CbGbCtD
Phenobarbital—CYP2B6—Dexamethasone—multiple sclerosis	0.0122	0.0165	CbGbCtD
Phenobarbital—ABCB1—Mitoxantrone—multiple sclerosis	0.012	0.0163	CbGbCtD
Phenobarbital—ABCB1—Betamethasone—multiple sclerosis	0.0107	0.0145	CbGbCtD
Phenobarbital—ABCB1—Prednisolone—multiple sclerosis	0.0106	0.0143	CbGbCtD
Phenobarbital—ABCB1—Prednisone—multiple sclerosis	0.01	0.0135	CbGbCtD
Phenobarbital—CYP3A4—Methylprednisolone—multiple sclerosis	0.00989	0.0134	CbGbCtD
Phenobarbital—CYP3A5—Dexamethasone—multiple sclerosis	0.0096	0.013	CbGbCtD
Phenobarbital—CYP2C8—Dexamethasone—multiple sclerosis	0.00923	0.0125	CbGbCtD
Phenobarbital—CYP2C19—Dexamethasone—multiple sclerosis	0.00774	0.0105	CbGbCtD
Phenobarbital—CYP3A4—Triamcinolone—multiple sclerosis	0.0075	0.0101	CbGbCtD
Phenobarbital—CYP3A4—Mitoxantrone—multiple sclerosis	0.00722	0.00975	CbGbCtD
Phenobarbital—CYP2C9—Dexamethasone—multiple sclerosis	0.00644	0.00869	CbGbCtD
Phenobarbital—CYP3A4—Betamethasone—multiple sclerosis	0.00643	0.00869	CbGbCtD
Phenobarbital—CYP3A4—Prednisolone—multiple sclerosis	0.00635	0.00858	CbGbCtD
Phenobarbital—ABCB1—Dexamethasone—multiple sclerosis	0.00625	0.00844	CbGbCtD
Phenobarbital—CYP3A4—Prednisone—multiple sclerosis	0.00599	0.0081	CbGbCtD
Phenobarbital—ABCB1—Methotrexate—multiple sclerosis	0.00502	0.00678	CbGbCtD
Phenobarbital—CYP3A4—Dexamethasone—multiple sclerosis	0.00374	0.00506	CbGbCtD
Phenobarbital—CHRNA4—peripheral nervous system—multiple sclerosis	0.00279	0.0639	CbGeAlD
Phenobarbital—GRIK2—nerve—multiple sclerosis	0.00271	0.062	CbGeAlD
Phenobarbital—CHRNA4—nerve—multiple sclerosis	0.00217	0.0498	CbGeAlD
Phenobarbital—GRIA2—brainstem—multiple sclerosis	0.00129	0.0295	CbGeAlD
Phenobarbital—GRIK2—brainstem—multiple sclerosis	0.00116	0.0266	CbGeAlD
Phenobarbital—GRIK2—retina—multiple sclerosis	0.00112	0.0257	CbGeAlD
Phenobarbital—CYP4B1—cerebellum—multiple sclerosis	0.000951	0.0218	CbGeAlD
Phenobarbital—CHRNA4—brainstem—multiple sclerosis	0.000934	0.0214	CbGeAlD
Phenobarbital—CHRNA7—retina—multiple sclerosis	0.000913	0.0209	CbGeAlD
Phenobarbital—GRIA2—midbrain—multiple sclerosis	0.00082	0.0188	CbGeAlD
Phenobarbital—GRIK2—medulla oblongata—multiple sclerosis	0.00081	0.0186	CbGeAlD
Phenobarbital—GABRA1—brainstem—multiple sclerosis	0.000808	0.0185	CbGeAlD
Phenobarbital—GRIA2—spinal cord—multiple sclerosis	0.0008	0.0183	CbGeAlD
Phenobarbital—CYP4B1—brain—multiple sclerosis	0.000772	0.0177	CbGeAlD
Phenobarbital—GRIK2—midbrain—multiple sclerosis	0.00074	0.017	CbGeAlD
Phenobarbital—GRIK2—spinal cord—multiple sclerosis	0.000722	0.0166	CbGeAlD
Phenobarbital—GRIA2—nervous system—multiple sclerosis	0.000674	0.0154	CbGeAlD
Phenobarbital—GRIA2—central nervous system—multiple sclerosis	0.000649	0.0149	CbGeAlD
Phenobarbital—GRIA2—cerebellum—multiple sclerosis	0.000634	0.0145	CbGeAlD
Phenobarbital—CHRFAM7A—nervous system—multiple sclerosis	0.000614	0.0141	CbGeAlD
Phenobarbital—GRIK2—nervous system—multiple sclerosis	0.000609	0.014	CbGeAlD
Phenobarbital—SLCO2A1—nervous system—multiple sclerosis	0.000604	0.0139	CbGeAlD
Phenobarbital—CHRNA4—midbrain—multiple sclerosis	0.000595	0.0136	CbGeAlD
Phenobarbital—CHRFAM7A—central nervous system—multiple sclerosis	0.000591	0.0135	CbGeAlD
Phenobarbital—GRIK2—central nervous system—multiple sclerosis	0.000586	0.0134	CbGeAlD
Phenobarbital—SLCO2A1—central nervous system—multiple sclerosis	0.000582	0.0133	CbGeAlD
Phenobarbital—CHRNA4—spinal cord—multiple sclerosis	0.000581	0.0133	CbGeAlD
Phenobarbital—GRIK2—cerebellum—multiple sclerosis	0.000573	0.0131	CbGeAlD
Phenobarbital—GABRA1—medulla oblongata—multiple sclerosis	0.000563	0.0129	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.000562	0.00541	CcSEcCtD
Phenobarbital—Erythema—Cladribine—multiple sclerosis	0.000545	0.00524	CcSEcCtD
Phenobarbital—Necrosis—Methotrexate—multiple sclerosis	0.00052	0.00501	CcSEcCtD
Phenobarbital—Dizziness—Fingolimod—multiple sclerosis	0.000519	0.00499	CcSEcCtD
Phenobarbital—GRIA2—brain—multiple sclerosis	0.000515	0.0118	CbGeAlD
Phenobarbital—GABRA1—midbrain—multiple sclerosis	0.000515	0.0118	CbGeAlD
Phenobarbital—Dermatitis bullous—Prednisolone—multiple sclerosis	0.00051	0.00491	CcSEcCtD
Phenobarbital—GABRA1—spinal cord—multiple sclerosis	0.000502	0.0115	CbGeAlD
Phenobarbital—CHRNA7—nervous system—multiple sclerosis	0.000496	0.0114	CbGeAlD
Phenobarbital—Headache—Fingolimod—multiple sclerosis	0.000491	0.00473	CcSEcCtD
Phenobarbital—CHRNA4—nervous system—multiple sclerosis	0.000489	0.0112	CbGeAlD
Phenobarbital—Apnoea—Methotrexate—multiple sclerosis	0.000482	0.00463	CcSEcCtD
Phenobarbital—Erythema multiforme—Azathioprine—multiple sclerosis	0.000481	0.00463	CcSEcCtD
Phenobarbital—Affect lability—Prednisolone—multiple sclerosis	0.00048	0.00462	CcSEcCtD
Phenobarbital—CHRNA7—central nervous system—multiple sclerosis	0.000477	0.0109	CbGeAlD
Phenobarbital—CHRNA4—central nervous system—multiple sclerosis	0.000471	0.0108	CbGeAlD
Phenobarbital—Dermatitis bullous—Triamcinolone—multiple sclerosis	0.000469	0.00452	CcSEcCtD
Phenobarbital—CHRFAM7A—brain—multiple sclerosis	0.000469	0.0108	CbGeAlD
Phenobarbital—Extravasation—Methotrexate—multiple sclerosis	0.000468	0.0045	CcSEcCtD
Phenobarbital—CYP2A6—cerebellum—multiple sclerosis	0.000466	0.0107	CbGeAlD
Phenobarbital—GRIK2—brain—multiple sclerosis	0.000465	0.0107	CbGeAlD
Phenobarbital—ABCC3—nervous system—multiple sclerosis	0.000464	0.0106	CbGeAlD
Phenobarbital—Myalgia—Cladribine—multiple sclerosis	0.000464	0.00446	CcSEcCtD
Phenobarbital—Arthralgia—Cladribine—multiple sclerosis	0.000464	0.00446	CcSEcCtD
Phenobarbital—Anxiety—Cladribine—multiple sclerosis	0.000462	0.00445	CcSEcCtD
Phenobarbital—Mood swings—Prednisolone—multiple sclerosis	0.000462	0.00445	CcSEcCtD
Phenobarbital—SLCO2A1—brain—multiple sclerosis	0.000462	0.0106	CbGeAlD
Phenobarbital—CHRNA4—cerebellum—multiple sclerosis	0.00046	0.0106	CbGeAlD
Phenobarbital—Drowsiness—Mitoxantrone—multiple sclerosis	0.000458	0.00441	CcSEcCtD
Phenobarbital—Renal failure—Mitoxantrone—multiple sclerosis	0.00045	0.00434	CcSEcCtD
Phenobarbital—Confusional state—Cladribine—multiple sclerosis	0.000448	0.00432	CcSEcCtD
Phenobarbital—ABCC3—central nervous system—multiple sclerosis	0.000447	0.0102	CbGeAlD
Phenobarbital—Affect lability—Triamcinolone—multiple sclerosis	0.000442	0.00425	CcSEcCtD
Phenobarbital—Affect lability—Methylprednisolone—multiple sclerosis	0.000441	0.00424	CcSEcCtD
Phenobarbital—Irritability—Methylprednisolone—multiple sclerosis	0.000427	0.00411	CcSEcCtD
Phenobarbital—Hyperkinesia—Prednisone—multiple sclerosis	0.000426	0.0041	CcSEcCtD
Phenobarbital—Dermatitis bullous—Betamethasone—multiple sclerosis	0.000426	0.0041	CcSEcCtD
Phenobarbital—Dermatitis bullous—Dexamethasone—multiple sclerosis	0.000426	0.0041	CcSEcCtD
Phenobarbital—Mood swings—Triamcinolone—multiple sclerosis	0.000425	0.00409	CcSEcCtD
Phenobarbital—Mood swings—Methylprednisolone—multiple sclerosis	0.000424	0.00408	CcSEcCtD
Phenobarbital—GABRA1—nervous system—multiple sclerosis	0.000423	0.0097	CbGeAlD
Phenobarbital—Bradycardia—Mitoxantrone—multiple sclerosis	0.000419	0.00403	CcSEcCtD
Phenobarbital—Respiratory failure—Methotrexate—multiple sclerosis	0.000416	0.004	CcSEcCtD
Phenobarbital—Hypotension—Cladribine—multiple sclerosis	0.000416	0.004	CcSEcCtD
Phenobarbital—Lethargy—Dexamethasone—multiple sclerosis	0.000415	0.004	CcSEcCtD
Phenobarbital—Lethargy—Betamethasone—multiple sclerosis	0.000415	0.004	CcSEcCtD
Phenobarbital—Hepatitis—Mitoxantrone—multiple sclerosis	0.000411	0.00396	CcSEcCtD
Phenobarbital—GABRA1—central nervous system—multiple sclerosis	0.000407	0.00934	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000405	0.0039	CcSEcCtD
Phenobarbital—Affect lability—Dexamethasone—multiple sclerosis	0.000401	0.00386	CcSEcCtD
Phenobarbital—Affect lability—Betamethasone—multiple sclerosis	0.000401	0.00386	CcSEcCtD
Phenobarbital—GABRA1—cerebellum—multiple sclerosis	0.000398	0.00913	CbGeAlD
Phenobarbital—Somnolence—Cladribine—multiple sclerosis	0.000395	0.00381	CcSEcCtD
Phenobarbital—Depressed level of consciousness—Methotrexate—multiple sclerosis	0.000394	0.00379	CcSEcCtD
Phenobarbital—Irritability—Betamethasone—multiple sclerosis	0.000389	0.00374	CcSEcCtD
Phenobarbital—Irritability—Dexamethasone—multiple sclerosis	0.000389	0.00374	CcSEcCtD
Phenobarbital—Asthma—Triamcinolone—multiple sclerosis	0.000388	0.00373	CcSEcCtD
Phenobarbital—Mood swings—Dexamethasone—multiple sclerosis	0.000386	0.00371	CcSEcCtD
Phenobarbital—Mood swings—Betamethasone—multiple sclerosis	0.000386	0.00371	CcSEcCtD
Phenobarbital—Pain—Cladribine—multiple sclerosis	0.00038	0.00366	CcSEcCtD
Phenobarbital—Constipation—Cladribine—multiple sclerosis	0.00038	0.00366	CcSEcCtD
Phenobarbital—CHRNA7—brain—multiple sclerosis	0.000379	0.00869	CbGeAlD
Phenobarbital—CYP2A6—brain—multiple sclerosis	0.000379	0.00868	CbGeAlD
Phenobarbital—Arthralgia—Azathioprine—multiple sclerosis	0.000377	0.00363	CcSEcCtD
Phenobarbital—Myalgia—Azathioprine—multiple sclerosis	0.000377	0.00363	CcSEcCtD
Phenobarbital—CHRNA4—brain—multiple sclerosis	0.000374	0.00857	CbGeAlD
Phenobarbital—Coma—Methotrexate—multiple sclerosis	0.000373	0.00359	CcSEcCtD
Phenobarbital—Feeling abnormal—Cladribine—multiple sclerosis	0.000366	0.00353	CcSEcCtD
Phenobarbital—CYP1B1—nervous system—multiple sclerosis	0.000363	0.00832	CbGeAlD
Phenobarbital—Lethargy—Prednisone—multiple sclerosis	0.000362	0.00348	CcSEcCtD
Phenobarbital—Erythema—Mitoxantrone—multiple sclerosis	0.000358	0.00345	CcSEcCtD
Phenobarbital—ABCC3—brain—multiple sclerosis	0.000355	0.00813	CbGeAlD
Phenobarbital—Urticaria—Cladribine—multiple sclerosis	0.000353	0.0034	CcSEcCtD
Phenobarbital—Body temperature increased—Cladribine—multiple sclerosis	0.000352	0.00338	CcSEcCtD
Phenobarbital—CYP1B1—central nervous system—multiple sclerosis	0.00035	0.00801	CbGeAlD
Phenobarbital—Affect lability—Prednisone—multiple sclerosis	0.000349	0.00336	CcSEcCtD
Phenobarbital—Bradycardia—Prednisolone—multiple sclerosis	0.000344	0.00331	CcSEcCtD
Phenobarbital—CYP1B1—cerebellum—multiple sclerosis	0.000342	0.00783	CbGeAlD
Phenobarbital—Irritability—Prednisone—multiple sclerosis	0.000338	0.00326	CcSEcCtD
Phenobarbital—Hypotension—Azathioprine—multiple sclerosis	0.000338	0.00325	CcSEcCtD
Phenobarbital—Mood swings—Prednisone—multiple sclerosis	0.000336	0.00323	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000329	0.00317	CcSEcCtD
Phenobarbital—Hypersensitivity—Cladribine—multiple sclerosis	0.000328	0.00315	CcSEcCtD
Phenobarbital—GABRA1—brain—multiple sclerosis	0.000323	0.00741	CbGeAlD
Phenobarbital—Bradycardia—Triamcinolone—multiple sclerosis	0.000316	0.00304	CcSEcCtD
Phenobarbital—Bradycardia—Methylprednisolone—multiple sclerosis	0.000315	0.00303	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000314	0.00302	CcSEcCtD
Phenobarbital—CYP2E1—medulla oblongata—multiple sclerosis	0.000312	0.00714	CbGeAlD
Phenobarbital—Hallucination—Methylprednisolone—multiple sclerosis	0.000308	0.00297	CcSEcCtD
Phenobarbital—ABCC1—cerebellum—multiple sclerosis	0.000307	0.00705	CbGeAlD
Phenobarbital—Arthralgia—Mitoxantrone—multiple sclerosis	0.000305	0.00293	CcSEcCtD
Phenobarbital—Myalgia—Mitoxantrone—multiple sclerosis	0.000305	0.00293	CcSEcCtD
Phenobarbital—Anxiety—Mitoxantrone—multiple sclerosis	0.000304	0.00292	CcSEcCtD
Phenobarbital—Lethargy—Methotrexate—multiple sclerosis	0.000302	0.00291	CcSEcCtD
Phenobarbital—Feeling abnormal—Azathioprine—multiple sclerosis	0.000298	0.00287	CcSEcCtD
Phenobarbital—Confusional state—Mitoxantrone—multiple sclerosis	0.000295	0.00284	CcSEcCtD
Phenobarbital—Dizziness—Cladribine—multiple sclerosis	0.000294	0.00283	CcSEcCtD
Phenobarbital—Erythema—Prednisolone—multiple sclerosis	0.000294	0.00283	CcSEcCtD
Phenobarbital—Shock—Mitoxantrone—multiple sclerosis	0.000288	0.00277	CcSEcCtD
Phenobarbital—Bradycardia—Betamethasone—multiple sclerosis	0.000287	0.00276	CcSEcCtD
Phenobarbital—Bradycardia—Dexamethasone—multiple sclerosis	0.000287	0.00276	CcSEcCtD
Phenobarbital—Body temperature increased—Azathioprine—multiple sclerosis	0.000286	0.00275	CcSEcCtD
Phenobarbital—Irritability—Methotrexate—multiple sclerosis	0.000283	0.00272	CcSEcCtD
Phenobarbital—Vomiting—Cladribine—multiple sclerosis	0.000283	0.00272	CcSEcCtD
Phenobarbital—Mood swings—Methotrexate—multiple sclerosis	0.000281	0.0027	CcSEcCtD
Phenobarbital—Rash—Cladribine—multiple sclerosis	0.00028	0.0027	CcSEcCtD
Phenobarbital—Hallucination—Dexamethasone—multiple sclerosis	0.00028	0.0027	CcSEcCtD
Phenobarbital—Hallucination—Betamethasone—multiple sclerosis	0.00028	0.0027	CcSEcCtD
Phenobarbital—Dermatitis—Cladribine—multiple sclerosis	0.00028	0.0027	CcSEcCtD
Phenobarbital—Ataxia—Methotrexate—multiple sclerosis	0.000279	0.00268	CcSEcCtD
Phenobarbital—Headache—Cladribine—multiple sclerosis	0.000279	0.00268	CcSEcCtD
Phenobarbital—CYP2E1—spinal cord—multiple sclerosis	0.000278	0.00637	CbGeAlD
Phenobarbital—CYP1B1—brain—multiple sclerosis	0.000278	0.00636	CbGeAlD
Phenobarbital—Hypotension—Mitoxantrone—multiple sclerosis	0.000273	0.00263	CcSEcCtD
Phenobarbital—Erythema—Triamcinolone—multiple sclerosis	0.00027	0.0026	CcSEcCtD
Phenobarbital—Erythema—Methylprednisolone—multiple sclerosis	0.00027	0.00259	CcSEcCtD
Phenobarbital—Angioedema—Prednisolone—multiple sclerosis	0.000268	0.00258	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000267	0.00257	CcSEcCtD
Phenobarbital—Hypersensitivity—Azathioprine—multiple sclerosis	0.000266	0.00256	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000266	0.00256	CcSEcCtD
Phenobarbital—Nausea—Cladribine—multiple sclerosis	0.000264	0.00254	CcSEcCtD
Phenobarbital—Vertigo—Prednisolone—multiple sclerosis	0.000264	0.00254	CcSEcCtD
Phenobarbital—Syncope—Prednisolone—multiple sclerosis	0.000263	0.00254	CcSEcCtD
Phenobarbital—Somnolence—Mitoxantrone—multiple sclerosis	0.00026	0.0025	CcSEcCtD
Phenobarbital—Loss of consciousness—Prednisolone—multiple sclerosis	0.000258	0.00249	CcSEcCtD
Phenobarbital—CYP1A1—nervous system—multiple sclerosis	0.000257	0.00588	CbGeAlD
Phenobarbital—Asthma—Methotrexate—multiple sclerosis	0.000256	0.00246	CcSEcCtD
Phenobarbital—Constipation—Mitoxantrone—multiple sclerosis	0.00025	0.00241	CcSEcCtD
Phenobarbital—Pain—Mitoxantrone—multiple sclerosis	0.00025	0.00241	CcSEcCtD
Phenobarbital—Bradycardia—Prednisone—multiple sclerosis	0.00025	0.0024	CcSEcCtD
Phenobarbital—ABCC1—brain—multiple sclerosis	0.00025	0.00572	CbGeAlD
Phenobarbital—CYP2B6—nervous system—multiple sclerosis	0.000249	0.00572	CbGeAlD
Phenobarbital—CYP1A1—central nervous system—multiple sclerosis	0.000247	0.00567	CbGeAlD
Phenobarbital—Angioedema—Triamcinolone—multiple sclerosis	0.000247	0.00238	CcSEcCtD
Phenobarbital—Angioedema—Methylprednisolone—multiple sclerosis	0.000246	0.00237	CcSEcCtD
Phenobarbital—ABCB1—retina—multiple sclerosis	0.000246	0.00563	CbGeAlD
Phenobarbital—Erythema—Betamethasone—multiple sclerosis	0.000245	0.00236	CcSEcCtD
Phenobarbital—Erythema—Dexamethasone—multiple sclerosis	0.000245	0.00236	CcSEcCtD
Phenobarbital—Hallucination—Prednisone—multiple sclerosis	0.000244	0.00235	CcSEcCtD
Phenobarbital—Vertigo—Triamcinolone—multiple sclerosis	0.000243	0.00234	CcSEcCtD
Phenobarbital—Syncope—Triamcinolone—multiple sclerosis	0.000242	0.00233	CcSEcCtD
Phenobarbital—Vertigo—Methylprednisolone—multiple sclerosis	0.000242	0.00233	CcSEcCtD
Phenobarbital—Syncope—Methylprednisolone—multiple sclerosis	0.000242	0.00233	CcSEcCtD
Phenobarbital—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000241	0.00232	CcSEcCtD
Phenobarbital—CYP2B6—central nervous system—multiple sclerosis	0.00024	0.00551	CbGeAlD
Phenobarbital—Dizziness—Azathioprine—multiple sclerosis	0.000239	0.0023	CcSEcCtD
Phenobarbital—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000237	0.00229	CcSEcCtD
Phenobarbital—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000237	0.00228	CcSEcCtD
Phenobarbital—Shock—Prednisolone—multiple sclerosis	0.000236	0.00227	CcSEcCtD
Phenobarbital—CYP2E1—nervous system—multiple sclerosis	0.000234	0.00537	CbGeAlD
Phenobarbital—Urticaria—Mitoxantrone—multiple sclerosis	0.000232	0.00223	CcSEcCtD
Phenobarbital—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000231	0.00222	CcSEcCtD
Phenobarbital—Myalgia—Triamcinolone—multiple sclerosis	0.00023	0.00221	CcSEcCtD
Phenobarbital—Vomiting—Azathioprine—multiple sclerosis	0.00023	0.00221	CcSEcCtD
Phenobarbital—Arthralgia—Methylprednisolone—multiple sclerosis	0.00023	0.00221	CcSEcCtD
Phenobarbital—Myalgia—Methylprednisolone—multiple sclerosis	0.00023	0.00221	CcSEcCtD
Phenobarbital—Anxiety—Methylprednisolone—multiple sclerosis	0.000229	0.0022	CcSEcCtD
Phenobarbital—Drowsiness—Methotrexate—multiple sclerosis	0.000228	0.0022	CcSEcCtD
Phenobarbital—Rash—Azathioprine—multiple sclerosis	0.000228	0.00219	CcSEcCtD
Phenobarbital—Dermatitis—Azathioprine—multiple sclerosis	0.000228	0.00219	CcSEcCtD
Phenobarbital—Headache—Azathioprine—multiple sclerosis	0.000227	0.00218	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000226	0.00218	CcSEcCtD
Phenobarbital—CYP2E1—central nervous system—multiple sclerosis	0.000225	0.00517	CbGeAlD
Phenobarbital—Renal failure—Methotrexate—multiple sclerosis	0.000224	0.00216	CcSEcCtD
Phenobarbital—Angioedema—Betamethasone—multiple sclerosis	0.000224	0.00216	CcSEcCtD
Phenobarbital—Angioedema—Dexamethasone—multiple sclerosis	0.000224	0.00216	CcSEcCtD
Phenobarbital—Confusional state—Methylprednisolone—multiple sclerosis	0.000222	0.00214	CcSEcCtD
Phenobarbital—CYP2E1—cerebellum—multiple sclerosis	0.00022	0.00505	CbGeAlD
Phenobarbital—Vertigo—Betamethasone—multiple sclerosis	0.00022	0.00212	CcSEcCtD
Phenobarbital—Vertigo—Dexamethasone—multiple sclerosis	0.00022	0.00212	CcSEcCtD
Phenobarbital—Syncope—Dexamethasone—multiple sclerosis	0.00022	0.00212	CcSEcCtD
Phenobarbital—Syncope—Betamethasone—multiple sclerosis	0.00022	0.00212	CcSEcCtD
Phenobarbital—Shock—Triamcinolone—multiple sclerosis	0.000217	0.00209	CcSEcCtD
Phenobarbital—Shock—Methylprednisolone—multiple sclerosis	0.000216	0.00208	CcSEcCtD
Phenobarbital—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000215	0.00207	CcSEcCtD
Phenobarbital—Loss of consciousness—Betamethasone—multiple sclerosis	0.000215	0.00207	CcSEcCtD
Phenobarbital—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000215	0.00207	CcSEcCtD
Phenobarbital—Nausea—Azathioprine—multiple sclerosis	0.000215	0.00207	CcSEcCtD
Phenobarbital—Erythema—Prednisone—multiple sclerosis	0.000214	0.00206	CcSEcCtD
Phenobarbital—CYP2C8—brain—multiple sclerosis	0.000213	0.00487	CbGeAlD
Phenobarbital—Myalgia—Betamethasone—multiple sclerosis	0.000209	0.00201	CcSEcCtD
Phenobarbital—Myalgia—Dexamethasone—multiple sclerosis	0.000209	0.00201	CcSEcCtD
Phenobarbital—Anxiety—Dexamethasone—multiple sclerosis	0.000208	0.002	CcSEcCtD
Phenobarbital—Anxiety—Betamethasone—multiple sclerosis	0.000208	0.002	CcSEcCtD
Phenobarbital—Hypotension—Methylprednisolone—multiple sclerosis	0.000206	0.00198	CcSEcCtD
Phenobarbital—Pain—Prednisolone—multiple sclerosis	0.000205	0.00197	CcSEcCtD
Phenobarbital—Hepatitis—Methotrexate—multiple sclerosis	0.000205	0.00197	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000201	0.00193	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.0002	0.00193	CcSEcCtD
Phenobarbital—Feeling abnormal—Prednisolone—multiple sclerosis	0.000198	0.0019	CcSEcCtD
Phenobarbital—Shock—Betamethasone—multiple sclerosis	0.000197	0.00189	CcSEcCtD
Phenobarbital—Shock—Dexamethasone—multiple sclerosis	0.000197	0.00189	CcSEcCtD
Phenobarbital—CYP1A1—brain—multiple sclerosis	0.000196	0.0045	CbGeAlD
Phenobarbital—Agitation—Prednisone—multiple sclerosis	0.000196	0.00189	CcSEcCtD
Phenobarbital—Angioedema—Prednisone—multiple sclerosis	0.000195	0.00188	CcSEcCtD
Phenobarbital—Erythema multiforme—Methotrexate—multiple sclerosis	0.000194	0.00187	CcSEcCtD
Phenobarbital—Vertigo—Prednisone—multiple sclerosis	0.000192	0.00185	CcSEcCtD
Phenobarbital—Syncope—Prednisone—multiple sclerosis	0.000191	0.00184	CcSEcCtD
Phenobarbital—CYP2B6—brain—multiple sclerosis	0.000191	0.00437	CbGeAlD
Phenobarbital—Urticaria—Prednisolone—multiple sclerosis	0.00019	0.00183	CcSEcCtD
Phenobarbital—Pain—Triamcinolone—multiple sclerosis	0.000189	0.00182	CcSEcCtD
Phenobarbital—CYP3A4—nervous system—multiple sclerosis	0.000188	0.00432	CbGeAlD
Phenobarbital—Loss of consciousness—Prednisone—multiple sclerosis	0.000188	0.00181	CcSEcCtD
Phenobarbital—Hypotension—Dexamethasone—multiple sclerosis	0.000187	0.0018	CcSEcCtD
Phenobarbital—Hypotension—Betamethasone—multiple sclerosis	0.000187	0.0018	CcSEcCtD
Phenobarbital—Vomiting—Mitoxantrone—multiple sclerosis	0.000186	0.00179	CcSEcCtD
Phenobarbital—Rash—Mitoxantrone—multiple sclerosis	0.000184	0.00177	CcSEcCtD
Phenobarbital—Dermatitis—Mitoxantrone—multiple sclerosis	0.000184	0.00177	CcSEcCtD
Phenobarbital—Headache—Mitoxantrone—multiple sclerosis	0.000183	0.00176	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000182	0.00175	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000182	0.00175	CcSEcCtD
Phenobarbital—Myalgia—Prednisone—multiple sclerosis	0.000182	0.00175	CcSEcCtD
Phenobarbital—Arthralgia—Prednisone—multiple sclerosis	0.000182	0.00175	CcSEcCtD
Phenobarbital—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000182	0.00175	CcSEcCtD
Phenobarbital—CYP3A4—central nervous system—multiple sclerosis	0.000181	0.00416	CbGeAlD
Phenobarbital—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000181	0.00175	CcSEcCtD
Phenobarbital—Anxiety—Prednisone—multiple sclerosis	0.000181	0.00174	CcSEcCtD
Phenobarbital—CYP2E1—brain—multiple sclerosis	0.000179	0.0041	CbGeAlD
Phenobarbital—Erythema—Methotrexate—multiple sclerosis	0.000178	0.00172	CcSEcCtD
Phenobarbital—ABCB1—medulla oblongata—multiple sclerosis	0.000177	0.00407	CbGeAlD
Phenobarbital—Hypersensitivity—Prednisolone—multiple sclerosis	0.000177	0.0017	CcSEcCtD
Phenobarbital—Urticaria—Triamcinolone—multiple sclerosis	0.000175	0.00169	CcSEcCtD
Phenobarbital—Urticaria—Methylprednisolone—multiple sclerosis	0.000175	0.00168	CcSEcCtD
Phenobarbital—Body temperature increased—Triamcinolone—multiple sclerosis	0.000174	0.00168	CcSEcCtD
Phenobarbital—Nausea—Mitoxantrone—multiple sclerosis	0.000174	0.00167	CcSEcCtD
Phenobarbital—Shock—Prednisone—multiple sclerosis	0.000171	0.00165	CcSEcCtD
Phenobarbital—Pain—Betamethasone—multiple sclerosis	0.000171	0.00165	CcSEcCtD
Phenobarbital—Pain—Dexamethasone—multiple sclerosis	0.000171	0.00165	CcSEcCtD
Phenobarbital—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000165	0.00159	CcSEcCtD
Phenobarbital—Feeling abnormal—Betamethasone—multiple sclerosis	0.000165	0.00159	CcSEcCtD
Phenobarbital—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000162	0.00156	CcSEcCtD
Phenobarbital—ABCB1—midbrain—multiple sclerosis	0.000162	0.00372	CbGeAlD
Phenobarbital—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000162	0.00156	CcSEcCtD
Phenobarbital—Vertigo—Methotrexate—multiple sclerosis	0.00016	0.00154	CcSEcCtD
Phenobarbital—Urticaria—Dexamethasone—multiple sclerosis	0.000159	0.00153	CcSEcCtD
Phenobarbital—Urticaria—Betamethasone—multiple sclerosis	0.000159	0.00153	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000159	0.00153	CcSEcCtD
Phenobarbital—Dizziness—Prednisolone—multiple sclerosis	0.000159	0.00153	CcSEcCtD
Phenobarbital—ABCB1—spinal cord—multiple sclerosis	0.000158	0.00363	CbGeAlD
Phenobarbital—Body temperature increased—Dexamethasone—multiple sclerosis	0.000158	0.00152	CcSEcCtD
Phenobarbital—Body temperature increased—Betamethasone—multiple sclerosis	0.000158	0.00152	CcSEcCtD
Phenobarbital—Myalgia—Methotrexate—multiple sclerosis	0.000152	0.00146	CcSEcCtD
Phenobarbital—Arthralgia—Methotrexate—multiple sclerosis	0.000152	0.00146	CcSEcCtD
Phenobarbital—Rash—Prednisolone—multiple sclerosis	0.000151	0.00146	CcSEcCtD
Phenobarbital—Dermatitis—Prednisolone—multiple sclerosis	0.000151	0.00145	CcSEcCtD
Phenobarbital—Headache—Prednisolone—multiple sclerosis	0.00015	0.00145	CcSEcCtD
Phenobarbital—Constipation—Prednisone—multiple sclerosis	0.000149	0.00143	CcSEcCtD
Phenobarbital—Confusional state—Methotrexate—multiple sclerosis	0.000147	0.00141	CcSEcCtD
Phenobarbital—Dizziness—Triamcinolone—multiple sclerosis	0.000146	0.0014	CcSEcCtD
Phenobarbital—Dizziness—Methylprednisolone—multiple sclerosis	0.000146	0.0014	CcSEcCtD
Phenobarbital—Feeling abnormal—Prednisone—multiple sclerosis	0.000144	0.00138	CcSEcCtD
Phenobarbital—Nausea—Prednisolone—multiple sclerosis	0.000142	0.00137	CcSEcCtD
Phenobarbital—Vomiting—Triamcinolone—multiple sclerosis	0.00014	0.00135	CcSEcCtD
Phenobarbital—Vomiting—Methylprednisolone—multiple sclerosis	0.00014	0.00135	CcSEcCtD
Phenobarbital—Rash—Triamcinolone—multiple sclerosis	0.000139	0.00134	CcSEcCtD
Phenobarbital—Dermatitis—Triamcinolone—multiple sclerosis	0.000139	0.00134	CcSEcCtD
Phenobarbital—Rash—Methylprednisolone—multiple sclerosis	0.000139	0.00134	CcSEcCtD
Phenobarbital—Dermatitis—Methylprednisolone—multiple sclerosis	0.000139	0.00133	CcSEcCtD
Phenobarbital—Urticaria—Prednisone—multiple sclerosis	0.000138	0.00133	CcSEcCtD
Phenobarbital—Headache—Triamcinolone—multiple sclerosis	0.000138	0.00133	CcSEcCtD
Phenobarbital—Headache—Methylprednisolone—multiple sclerosis	0.000138	0.00133	CcSEcCtD
Phenobarbital—Body temperature increased—Prednisone—multiple sclerosis	0.000138	0.00133	CcSEcCtD
Phenobarbital—Hypotension—Methotrexate—multiple sclerosis	0.000136	0.00131	CcSEcCtD
Phenobarbital—ABCB1—nervous system—multiple sclerosis	0.000133	0.00306	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000133	0.00128	CcSEcCtD
Phenobarbital—Dizziness—Dexamethasone—multiple sclerosis	0.000132	0.00127	CcSEcCtD
Phenobarbital—Dizziness—Betamethasone—multiple sclerosis	0.000132	0.00127	CcSEcCtD
Phenobarbital—Nausea—Triamcinolone—multiple sclerosis	0.000131	0.00126	CcSEcCtD
Phenobarbital—Nausea—Methylprednisolone—multiple sclerosis	0.000131	0.00126	CcSEcCtD
Phenobarbital—Somnolence—Methotrexate—multiple sclerosis	0.000129	0.00125	CcSEcCtD
Phenobarbital—ABCB1—central nervous system—multiple sclerosis	0.000128	0.00294	CbGeAlD
Phenobarbital—Hypersensitivity—Prednisone—multiple sclerosis	0.000128	0.00124	CcSEcCtD
Phenobarbital—Vomiting—Dexamethasone—multiple sclerosis	0.000127	0.00122	CcSEcCtD
Phenobarbital—Vomiting—Betamethasone—multiple sclerosis	0.000127	0.00122	CcSEcCtD
Phenobarbital—Rash—Dexamethasone—multiple sclerosis	0.000126	0.00121	CcSEcCtD
Phenobarbital—Rash—Betamethasone—multiple sclerosis	0.000126	0.00121	CcSEcCtD
Phenobarbital—Dermatitis—Betamethasone—multiple sclerosis	0.000126	0.00121	CcSEcCtD
Phenobarbital—Dermatitis—Dexamethasone—multiple sclerosis	0.000126	0.00121	CcSEcCtD
Phenobarbital—ABCB1—cerebellum—multiple sclerosis	0.000125	0.00288	CbGeAlD
Phenobarbital—Headache—Betamethasone—multiple sclerosis	0.000125	0.00121	CcSEcCtD
Phenobarbital—Headache—Dexamethasone—multiple sclerosis	0.000125	0.00121	CcSEcCtD
Phenobarbital—Pain—Methotrexate—multiple sclerosis	0.000125	0.0012	CcSEcCtD
Phenobarbital—Feeling abnormal—Methotrexate—multiple sclerosis	0.00012	0.00116	CcSEcCtD
Phenobarbital—Nausea—Dexamethasone—multiple sclerosis	0.000119	0.00114	CcSEcCtD
Phenobarbital—Nausea—Betamethasone—multiple sclerosis	0.000119	0.00114	CcSEcCtD
Phenobarbital—Urticaria—Methotrexate—multiple sclerosis	0.000116	0.00111	CcSEcCtD
Phenobarbital—Dizziness—Prednisone—multiple sclerosis	0.000115	0.00111	CcSEcCtD
Phenobarbital—Body temperature increased—Methotrexate—multiple sclerosis	0.000115	0.00111	CcSEcCtD
Phenobarbital—Vomiting—Prednisone—multiple sclerosis	0.000111	0.00107	CcSEcCtD
Phenobarbital—Rash—Prednisone—multiple sclerosis	0.00011	0.00106	CcSEcCtD
Phenobarbital—Dermatitis—Prednisone—multiple sclerosis	0.00011	0.00106	CcSEcCtD
Phenobarbital—Headache—Prednisone—multiple sclerosis	0.000109	0.00105	CcSEcCtD
Phenobarbital—Hypersensitivity—Methotrexate—multiple sclerosis	0.000107	0.00103	CcSEcCtD
Phenobarbital—Nausea—Prednisone—multiple sclerosis	0.000104	0.000996	CcSEcCtD
Phenobarbital—ABCB1—brain—multiple sclerosis	0.000102	0.00234	CbGeAlD
Phenobarbital—Dizziness—Methotrexate—multiple sclerosis	9.63e-05	0.000927	CcSEcCtD
Phenobarbital—Vomiting—Methotrexate—multiple sclerosis	9.26e-05	0.000891	CcSEcCtD
Phenobarbital—Rash—Methotrexate—multiple sclerosis	9.18e-05	0.000884	CcSEcCtD
Phenobarbital—Dermatitis—Methotrexate—multiple sclerosis	9.17e-05	0.000883	CcSEcCtD
Phenobarbital—Headache—Methotrexate—multiple sclerosis	9.12e-05	0.000878	CcSEcCtD
Phenobarbital—Nausea—Methotrexate—multiple sclerosis	8.65e-05	0.000833	CcSEcCtD
Phenobarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.86e-05	0.000344	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—RRM1—multiple sclerosis	3.85e-05	0.000343	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	3.82e-05	0.00034	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—CYP24A1—multiple sclerosis	3.82e-05	0.00034	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—CYP27B1—multiple sclerosis	3.82e-05	0.00034	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.81e-05	0.000339	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.81e-05	0.000339	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—RRM1—multiple sclerosis	3.8e-05	0.000338	CbGpPWpGaD
Phenobarbital—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.77e-05	0.000336	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.73e-05	0.000332	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.71e-05	0.00033	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—RRM1—multiple sclerosis	3.69e-05	0.000329	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—CYP27B1—multiple sclerosis	3.69e-05	0.000329	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—CYP24A1—multiple sclerosis	3.69e-05	0.000329	CbGpPWpGaD
Phenobarbital—CHRNA7—Neuronal System—MAPK1—multiple sclerosis	3.63e-05	0.000323	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.62e-05	0.000322	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.61e-05	0.000321	CbGpPWpGaD
Phenobarbital—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.59e-05	0.00032	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—SRM—multiple sclerosis	3.5e-05	0.000311	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—GPC5—multiple sclerosis	3.49e-05	0.000311	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—SRM—multiple sclerosis	3.42e-05	0.000305	CbGpPWpGaD
Phenobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.42e-05	0.000304	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—SRM—multiple sclerosis	3.42e-05	0.000304	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—GPC5—multiple sclerosis	3.38e-05	0.000301	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.37e-05	0.0003	CbGpPWpGaD
Phenobarbital—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	3.34e-05	0.000298	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	3.33e-05	0.000297	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	3.33e-05	0.000297	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.3e-05	0.000294	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.29e-05	0.000293	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.26e-05	0.00029	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.26e-05	0.00029	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.26e-05	0.00029	CbGpPWpGaD
Phenobarbital—CYP2B6—Biological oxidations—POMC—multiple sclerosis	3.24e-05	0.000289	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—SRM—multiple sclerosis	3.23e-05	0.000287	CbGpPWpGaD
Phenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.18e-05	0.000283	CbGpPWpGaD
Phenobarbital—CYP2E1—Biological oxidations—POMC—multiple sclerosis	3.17e-05	0.000283	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.17e-05	0.000282	CbGpPWpGaD
Phenobarbital—CYP3A5—Biological oxidations—POMC—multiple sclerosis	3.17e-05	0.000282	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.16e-05	0.000282	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.16e-05	0.000281	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.1e-05	0.000276	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	3.05e-05	0.000272	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	3.05e-05	0.000272	CbGpPWpGaD
Phenobarbital—GRIA2—Neuronal System—MAPK1—multiple sclerosis	3.05e-05	0.000271	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—GPC5—multiple sclerosis	3.05e-05	0.000271	CbGpPWpGaD
Phenobarbital—CYP1A1—Biological oxidations—POMC—multiple sclerosis	2.99e-05	0.000266	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.99e-05	0.000266	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—SRM—multiple sclerosis	2.96e-05	0.000264	CbGpPWpGaD
Phenobarbital—CHRNA4—Neuronal System—MAPK1—multiple sclerosis	2.96e-05	0.000263	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.95e-05	0.000263	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.95e-05	0.000263	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.9e-05	0.000258	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—RRM1—multiple sclerosis	2.89e-05	0.000258	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—APOE—multiple sclerosis	2.89e-05	0.000257	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.87e-05	0.000255	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—RRM1—multiple sclerosis	2.8e-05	0.000249	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—GPC5—multiple sclerosis	2.79e-05	0.000249	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.79e-05	0.000248	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.77e-05	0.000247	CbGpPWpGaD
Phenobarbital—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.77e-05	0.000247	CbGpPWpGaD
Phenobarbital—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.74e-05	0.000244	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—RPL5—multiple sclerosis	2.71e-05	0.000241	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—SRM—multiple sclerosis	2.64e-05	0.000235	CbGpPWpGaD
Phenobarbital—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	2.64e-05	0.000235	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.64e-05	0.000235	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—SLC11A1—multiple sclerosis	2.6e-05	0.000231	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—SRM—multiple sclerosis	2.58e-05	0.00023	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.57e-05	0.000229	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.57e-05	0.000229	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.52e-05	0.000225	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.5e-05	0.000223	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—BCHE—multiple sclerosis	2.5e-05	0.000222	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—POMC—multiple sclerosis	2.48e-05	0.000221	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	2.46e-05	0.000219	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	2.46e-05	0.000219	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.46e-05	0.000219	CbGpPWpGaD
Phenobarbital—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.45e-05	0.000218	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.41e-05	0.000215	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.41e-05	0.000215	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—SRM—multiple sclerosis	2.41e-05	0.000215	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.41e-05	0.000214	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.41e-05	0.000214	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.4e-05	0.000214	CbGpPWpGaD
Phenobarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.39e-05	0.000213	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.34e-05	0.000208	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—RRM1—multiple sclerosis	2.31e-05	0.000206	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	2.27e-05	0.000203	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	2.27e-05	0.000203	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—ALB—multiple sclerosis	2.26e-05	0.000201	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.25e-05	0.000201	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.25e-05	0.0002	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.24e-05	0.0002	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.24e-05	0.000199	CbGpPWpGaD
Phenobarbital—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.23e-05	0.000199	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.22e-05	0.000198	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—BCHE—multiple sclerosis	2.21e-05	0.000197	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.21e-05	0.000197	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.21e-05	0.000196	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.2e-05	0.000196	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—BCHE—multiple sclerosis	2.18e-05	0.000194	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.17e-05	0.000193	CbGpPWpGaD
Phenobarbital—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.13e-05	0.00019	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—BCHE—multiple sclerosis	2.12e-05	0.000189	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.09e-05	0.000186	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.09e-05	0.000186	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GPC5—multiple sclerosis	2.08e-05	0.000185	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CD28—multiple sclerosis	2.07e-05	0.000185	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—SRM—multiple sclerosis	2.06e-05	0.000183	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.04e-05	0.000181	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.93e-05	0.000172	CbGpPWpGaD
Phenobarbital—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.91e-05	0.00017	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.91e-05	0.00017	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.87e-05	0.000166	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.87e-05	0.000166	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.86e-05	0.000166	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.86e-05	0.000166	CbGpPWpGaD
Phenobarbital—GABRA1—Neuronal System—MAPK1—multiple sclerosis	1.83e-05	0.000163	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.83e-05	0.000163	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.82e-05	0.000162	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.82e-05	0.000162	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.82e-05	0.000162	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.82e-05	0.000162	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.76e-05	0.000157	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—RRM1—multiple sclerosis	1.72e-05	0.000154	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.7e-05	0.000152	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.7e-05	0.000151	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.7e-05	0.000151	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.7e-05	0.000151	CbGpPWpGaD
Phenobarbital—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.69e-05	0.000151	CbGpPWpGaD
Phenobarbital—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.67e-05	0.000149	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—BCHE—multiple sclerosis	1.66e-05	0.000148	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GPC5—multiple sclerosis	1.66e-05	0.000148	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.66e-05	0.000148	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—BCHE—multiple sclerosis	1.61e-05	0.000143	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SRM—multiple sclerosis	1.59e-05	0.000141	CbGpPWpGaD
Phenobarbital—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.59e-05	0.000141	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.58e-05	0.000141	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.55e-05	0.000138	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—APOE—multiple sclerosis	1.5e-05	0.000134	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CD86—multiple sclerosis	1.48e-05	0.000132	CbGpPWpGaD
Phenobarbital—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.47e-05	0.000131	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.45e-05	0.000129	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.45e-05	0.000129	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.45e-05	0.000129	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.42e-05	0.000126	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.41e-05	0.000126	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—RRM1—multiple sclerosis	1.38e-05	0.000123	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.34e-05	0.000119	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—APOE—multiple sclerosis	1.33e-05	0.000119	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.000118	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.33e-05	0.000118	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CCR5—multiple sclerosis	1.31e-05	0.000117	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—APOE—multiple sclerosis	1.31e-05	0.000117	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—POMC—multiple sclerosis	1.29e-05	0.000115	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.29e-05	0.000115	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—HLA-A—multiple sclerosis	1.28e-05	0.000114	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—APOE—multiple sclerosis	1.28e-05	0.000114	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.27e-05	0.000113	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.27e-05	0.000113	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.24e-05	0.000111	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.23e-05	0.000109	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—APOE—multiple sclerosis	1.19e-05	0.000106	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.18e-05	0.000105	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—ALB—multiple sclerosis	1.18e-05	0.000105	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.15e-05	0.000102	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—POMC—multiple sclerosis	1.14e-05	0.000102	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—POMC—multiple sclerosis	1.13e-05	0.0001	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.12e-05	9.97e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.12e-05	9.97e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.1e-05	9.79e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—POMC—multiple sclerosis	1.1e-05	9.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.09e-05	9.75e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CD80—multiple sclerosis	1.08e-05	9.61e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.07e-05	9.55e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.05e-05	9.38e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.05e-05	9.35e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.05e-05	9.33e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.05e-05	9.33e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—ALB—multiple sclerosis	1.04e-05	9.28e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—ALB—multiple sclerosis	1.03e-05	9.15e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.02e-05	9.12e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—APOE—multiple sclerosis	1e-05	8.9e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—ALB—multiple sclerosis	1e-05	8.9e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.98e-06	8.89e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—BCHE—multiple sclerosis	9.9e-06	8.82e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—APOE—multiple sclerosis	9.67e-06	8.61e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.6e-06	8.55e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.4e-06	8.37e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—TYK2—multiple sclerosis	9.11e-06	8.12e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—BCHE—multiple sclerosis	9.08e-06	8.08e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—APOE—multiple sclerosis	8.72e-06	7.77e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—POMC—multiple sclerosis	8.59e-06	7.65e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.57e-06	7.63e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.57e-06	7.63e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.53e-06	7.59e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.48e-06	7.55e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—POMC—multiple sclerosis	8.31e-06	7.4e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CD4—multiple sclerosis	8.24e-06	7.34e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—BCHE—multiple sclerosis	8.1e-06	7.21e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—APOE—multiple sclerosis	8e-06	7.12e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.96e-06	7.08e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—BCHE—multiple sclerosis	7.91e-06	7.04e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—ALB—multiple sclerosis	7.83e-06	6.97e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.82e-06	6.96e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—ALB—multiple sclerosis	7.58e-06	6.75e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—POMC—multiple sclerosis	7.49e-06	6.67e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.39e-06	6.58e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.33e-06	6.52e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—POMC—multiple sclerosis	6.87e-06	6.12e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—ALB—multiple sclerosis	6.83e-06	6.08e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.68e-06	5.95e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—APOE—multiple sclerosis	6.45e-06	5.74e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—STAT3—multiple sclerosis	6.38e-06	5.68e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—APOE—multiple sclerosis	6.32e-06	5.63e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.31e-06	5.62e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—APOE—multiple sclerosis	6.31e-06	5.61e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—ALB—multiple sclerosis	6.26e-06	5.58e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—APOE—multiple sclerosis	5.96e-06	5.3e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MYC—multiple sclerosis	5.93e-06	5.28e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—TGFB1—multiple sclerosis	5.92e-06	5.27e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MAPK1—multiple sclerosis	5.8e-06	5.17e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—POMC—multiple sclerosis	5.54e-06	4.93e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—APOE—multiple sclerosis	5.46e-06	4.86e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—POMC—multiple sclerosis	5.43e-06	4.83e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—POMC—multiple sclerosis	5.42e-06	4.82e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—POMC—multiple sclerosis	5.12e-06	4.56e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—ALB—multiple sclerosis	5.05e-06	4.5e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—ALB—multiple sclerosis	4.95e-06	4.41e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—ALB—multiple sclerosis	4.94e-06	4.4e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—APOE—multiple sclerosis	4.87e-06	4.34e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.87e-06	4.34e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—APOE—multiple sclerosis	4.76e-06	4.24e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—POMC—multiple sclerosis	4.69e-06	4.18e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—ALB—multiple sclerosis	4.67e-06	4.15e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—IL6—multiple sclerosis	4.46e-06	3.97e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—APOE—multiple sclerosis	4.44e-06	3.96e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ALB—multiple sclerosis	4.28e-06	3.81e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—POMC—multiple sclerosis	4.19e-06	3.73e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—POMC—multiple sclerosis	4.09e-06	3.64e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—POMC—multiple sclerosis	3.82e-06	3.4e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ALB—multiple sclerosis	3.82e-06	3.4e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—APOE—multiple sclerosis	3.8e-06	3.38e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—ALB—multiple sclerosis	3.73e-06	3.32e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ALB—multiple sclerosis	3.48e-06	3.1e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—POMC—multiple sclerosis	3.26e-06	2.91e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ALB—multiple sclerosis	2.97e-06	2.65e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—APOE—multiple sclerosis	2.93e-06	2.61e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—POMC—multiple sclerosis	2.52e-06	2.24e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ALB—multiple sclerosis	2.3e-06	2.04e-05	CbGpPWpGaD
